UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

POS0845 SCLERODERMIC HAND SENSOR: SMART TECHNOLOGY APPLIED TO RHEUMATOLOGY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.676-677

2021

Volltextzugriff (PDF)

POS1243 TELEMEDICINE AND MANAGEMENT OF THE PATIENT AFFECTED BY GIANT CELL ARTERITIS DURING THE COVID-19 PANDEMIC - TELEMACOV

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.904-905

2021

Volltextzugriff (PDF)

POS0675 THE COMPARATIVE 3-YEAR RETENTION RATE OF TARGETED-SYNTHETIC AND BIOLOGIC DRUGS FOR RHEUMATOID ARTHRITIS: REAL-LIFE DATA FROM THE ITALIAN GISEA REGISTRY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.582-582

2021

Volltextzugriff (PDF)

AB0468 Clinical and ultrasonographic effectiveness in two cohorts of rheumatoid arthritis patients treated with abatacept: a real life study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1395

2018

Volltextzugriff (PDF)

POS1021 THE PsABio STUDY IN ITALY: A REAL-WORLD COMPARISON OF THE PERSISTENCE, EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.778-779

2021

Volltextzugriff (PDF)

AB0455 Impact of one-year treatment with biotechnologic drugs on work disability and activity impairment in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1389

2018

Volltextzugriff (PDF)

Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients

Journal of endocrinological investigation, 2020-11, Vol.43 (11), p.1661-1667

2020

Volltextzugriff (PDF)

Th1- and Th17-Related Cytokines in Venous and Arterial Blood of Sclerodermic Patients with and without Digital Ulcers

BioMed research international, 2019, Vol.2019 (2019), p.1-5

2019

Volltextzugriff (PDF)

Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients

Scandinavian journal of rheumatology, 2020-11, Vol.49 (6), p.505-506

2020

Volltextzugriff (PDF)

Th-17 cytokines and interstitial lung involvement in systemic sclerosis

Journal of breath research, 2016-11, Vol.10 (4), p.046013-046013

2016

Volltextzugriff (PDF)

A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data

Clinical and experimental rheumatology, 2015-01, Vol.33 (1 Suppl 88), p.S82

2015

Volltextzugriff (PDF)

FRI0651 Quantitative chest ct predicts 8-years-mortality and comorbidity in systemic sclerosis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.847

2018

Volltextzugriff (PDF)

SAT0193 Early discontinuation of first line biological treatment with etanercept in patients with rheumatoid arthritis: results from the italian gisea registry

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.957

2018

Volltextzugriff (PDF)

SAT0223 Predictive factors of early failure to first line treatment with methotrexate in patients with rheumatoid arthritis. results from the gisea registry

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.972

2018

Volltextzugriff (PDF)

SAT0381 Safety and Efficacy of Switching from Innovator To Biosimilar Infliximab in Patients Affected by Spondyloarthritis. A 6-Month Observational Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.806-806

2016

Volltextzugriff (PDF)

AB0642 Large Vessel Involvement in Limited and Diffuse Systemic Sclerosis: A Pulse Wave Velocity Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1124-1124

2016

Volltextzugriff (PDF)

FRI0143 Influence of low-dose glucocorticoid treatment on persistence on biologic dmards therapy: real-life data from the italian gisea registry

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.615

2018

Volltextzugriff (PDF)

The repeatability of automated and clinician refraction

Optometry and vision science, 1998-08, Vol.75 (8), p.617-622

1998

Volltextzugriff (PDF)

Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study

Clinical and experimental rheumatology, 2015-11, Vol.33 (6), p.895

2015

Volltextzugriff (PDF)

AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1296

2018

Volltextzugriff (PDF)

AB0643 Th-17 Cytokines and Interstitial Lung Involvement in Systemic Sclerosis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1124-1124

2016

Volltextzugriff (PDF)

AB0332 Golimumab Efficacy in Rheumatoid Arthritis after Conventional and Biological Treatment: Data from The Italian Lorhen Registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1014-1015

2016

Volltextzugriff (PDF)

FRI0232 Factors Influencing The Choice of First and Second Line Biologic Therapy for The Treatment of Rheumatoid Arthritis: Real Life Data from The Italian Lorhen Registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.517-517

2016

Volltextzugriff (PDF)

FRI0174 Two-Year Retention Rate of Subcutaneous Anti-Tumor Necrosis Factor Agents for Rheumatoid Arthritis: A Retrospective Analysis of The Lorhen Registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.492-492

2016

Volltextzugriff (PDF)

SAT0391 The 8-Year Retention Rate of The First TNF-Inhibitor in The Treatment of Spondyloarthropathies: Real-Life Data from A Multicentric Local Registries

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.810-810

2016

Volltextzugriff (PDF)

1 – 25 von 517

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(331)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

POS0845 SCLERODERMIC HAND SENSOR: SMART TECHNOLOGY APPLIED TO RHEUMATOLOGY

POS1243 TELEMEDICINE AND MANAGEMENT OF THE PATIENT AFFECTED BY GIANT CELL ARTERITIS DURING THE COVID-19 PANDEMIC - TELEMACOV

POS0675 THE COMPARATIVE 3-YEAR RETENTION RATE OF TARGETED-SYNTHETIC AND BIOLOGIC DRUGS FOR RHEUMATOID ARTHRITIS: REAL-LIFE DATA FROM THE ITALIAN GISEA REGISTRY

AB0468 Clinical and ultrasonographic effectiveness in two cohorts of rheumatoid arthritis patients treated with abatacept: a real life study

POS1021 THE PsABio STUDY IN ITALY: A REAL-WORLD COMPARISON OF THE PERSISTENCE, EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS

AB0455 Impact of one-year treatment with biotechnologic drugs on work disability and activity impairment in patients with rheumatoid arthritis

Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients

Th1- and Th17-Related Cytokines in Venous and Arterial Blood of Sclerodermic Patients with and without Digital Ulcers

Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients

Th-17 cytokines and interstitial lung involvement in systemic sclerosis

A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data

FRI0651 Quantitative chest ct predicts 8-years-mortality and comorbidity in systemic sclerosis

SAT0193 Early discontinuation of first line biological treatment with etanercept in patients with rheumatoid arthritis: results from the italian gisea registry

SAT0223 Predictive factors of early failure to first line treatment with methotrexate in patients with rheumatoid arthritis. results from the gisea registry

SAT0381 Safety and Efficacy of Switching from Innovator To Biosimilar Infliximab in Patients Affected by Spondyloarthritis. A 6-Month Observational Study

AB0642 Large Vessel Involvement in Limited and Diffuse Systemic Sclerosis: A Pulse Wave Velocity Study

FRI0143 Influence of low-dose glucocorticoid treatment on persistence on biologic dmards therapy: real-life data from the italian gisea registry

The repeatability of automated and clinician refraction

Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study

AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea

AB0643 Th-17 Cytokines and Interstitial Lung Involvement in Systemic Sclerosis

AB0332 Golimumab Efficacy in Rheumatoid Arthritis after Conventional and Biological Treatment: Data from The Italian Lorhen Registry

FRI0232 Factors Influencing The Choice of First and Second Line Biologic Therapy for The Treatment of Rheumatoid Arthritis: Real Life Data from The Italian Lorhen Registry

FRI0174 Two-Year Retention Rate of Subcutaneous Anti-Tumor Necrosis Factor Agents for Rheumatoid Arthritis: A Retrospective Analysis of The Lorhen Registry

SAT0391 The 8-Year Retention Rate of The First TNF-Inhibitor in The Treatment of Spondyloarthropathies: Real-Life Data from A Multicentric Local Registries

Suchergebnisse filtern